Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries.

de Sousa A, Rabarijaona LP, Tenkorang O, Inkoom E, Ravelomanantena HV, Njarasoa S, Whang JN, Ndiaye JL, Ndiaye Y, Ndiaye M, Sow D, Akadiri G, Hassan J, Dicko A, Sagara I, Kubalalika P, Mathanga D, Bizuneh K, Randriasamimanana JR, Recht J, Bjelic I, Dodoo A.

J Infect Dis. 2012 Mar;205 Suppl 1:S82-90. doi: 10.1093/infdis/jir799.

PMID:
22315391
2.

Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.

Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C.

Lancet. 2009 Oct 31;374(9700):1533-42. doi: 10.1016/S0140-6736(09)61258-7. Epub 2009 Sep 16. Review.

PMID:
19765816
3.

Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.

de Sousa A, Rabarijaona LP, Ndiaye JL, Sow D, Ndyiae M, Hassan J, Lambo N, Adovohekpe P, Guidetti F, Recht J, Affo A.

Trop Med Int Health. 2012 Mar;17(3):308-15. doi: 10.1111/j.1365-3156.2011.02915.x. Epub 2011 Nov 29.

4.

Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.

Crawley J, Sismanidis C, Goodman T, Milligan P; WHO Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization in infants receiving Intermittent Preventive Treatment for malaria.

Lancet. 2012 Sep 15;380(9846):1001-10. doi: 10.1016/S0140-6736(12)60775-2. Epub 2012 Jul 30.

PMID:
22850358
5.

Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.

Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M, Sigauque B, Dobaño C, Mabunda S, DgeDge M, Alonso P, Menendez C.

J Infect Dis. 2006 Aug 1;194(3):276-85. Epub 2006 Jun 30.

PMID:
16826474
6.

A randomized controlled trial of extended intermittent preventive antimalarial treatment in infants.

Kobbe R, Kreuzberg C, Adjei S, Thompson B, Langefeld I, Thompson PA, Abruquah HH, Kreuels B, Ayim M, Busch W, Marks F, Amoah K, Opoku E, Meyer CG, Adjei O, May J.

Clin Infect Dis. 2007 Jul 1;45(1):16-25. Epub 2007 May 29.

PMID:
17554695
7.

[Pharmacovigilance and impact of intermittent preventive treatment with sulfadoxine-pyrimethamine in pregnant women in Sélingué, Mali].

Maiga AS, Diakite M, Diawara A, Sango HA, Coulibaly CO.

Mali Med. 2010;25(3):41-8. French.

PMID:
21441083
8.

Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.

Mayor A, Serra-Casas E, Sanz S, Aponte JJ, Macete E, Mandomando I, Puyol L, Berzosa P, Dobaño C, Aide P, Sacarlal J, Benito A, Alonso P, Menéndez C.

J Infect Dis. 2008 Jun 15;197(12):1737-42. doi: 10.1086/588144.

PMID:
18419347
9.

Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.

Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J, Kossou H, Fayomi B, Ayemonna P, Fievet N, Massougbodji A, Cot M.

J Infect Dis. 2009 Sep 15;200(6):991-1001. doi: 10.1086/605474.

PMID:
19656069
10.

Malaria pharmacovigilance in Africa: lessons from a pilot project in Mpumalanga Province, South Africa.

Mehta U, Durrheim D, Mabuza A, Blumberg L, Allen E, Barnes KI.

Drug Saf. 2007;30(10):899-910.

PMID:
17867727
11.

Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.

Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, Mensah N, Jaffar S, Baiden R, Hodgson A, Binka F, Greenwood B.

BMJ. 2005 Oct 1;331(7519):727-33.

12.

Inferiority of single-dose sulfadoxine-pyrimethamine intermittent preventive therapy for malaria during pregnancy among HIV-positive Zambian women.

Gill CJ, Macleod WB, Mwanakasale V, Chalwe V, Mwananyanda L, Champo D, Mukwamataba D, Chilengi R, Thea DM, Hamer DH.

J Infect Dis. 2007 Dec 1;196(11):1577-84. Epub 2007 Oct 25.

PMID:
18008240
13.

Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.

Dicko A, Toure SO, Traore M, Sagara I, Toure OB, Sissoko MS, Diallo AT, Rogier C, Salomon R, de Sousa A, Doumbo OK.

BMC Public Health. 2011 Jul 18;11:573. doi: 10.1186/1471-2458-11-573.

15.

Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings.

Gysels M, Pell C, Mathanga DP, Adongo P, Odhiambo F, Gosling R, Akweongo P, Mwangi R, Okello G, Mangesho P, Slutsker L, Kremsner PG, Grobusch MP, Hamel MJ, Newman RD, Pool R.

Malar J. 2009 Aug 10;8:191. doi: 10.1186/1475-2875-8-191.

16.

The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa.

Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, Biao P, Masika P, Matovu F, Otieno P, Gosling RD, Hamel M, Odhiambo FO, Grobusch MP, Kremsner PG, Chandramohan D, Aponte JJ, Egan A, Schellenberg D, Macete E, Slutsker L, Newman RD, Alonso P, Menéndez C, Tanner M.

PLoS One. 2010 Jun 15;5(6):e10313. doi: 10.1371/journal.pone.0010313.

17.

Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy.

Manzi F, Schellenberg J, Hamis Y, Mushi AK, Shirima K, Mwita A, Simba A, Rusibamayila N, Kitambi M, Tanner M, Alonso P, Mshinda H, Schellenberg D.

Trans R Soc Trop Med Hyg. 2009 Jan;103(1):79-86. doi: 10.1016/j.trstmh.2008.08.014. Epub 2008 Sep 26.

PMID:
18823639
18.

Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.

Kabanywanyi AM, Mulure N, Migoha C, Malila A, Lengeler C, Schlienger R, Genton B.

Malar J. 2010 Jul 14;9:205. doi: 10.1186/1475-2875-9-205.

19.

Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.

Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ.

J Infect Dis. 2007 Dec 1;196(11):1585-94. Epub 2007 Oct 25.

PMID:
18008241
20.

The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.

Pool R, Mushi A, Schellenberg JA, Mrisho M, Alonso P, Montgomery C, Tanner M, Mshinda H, Schellenberg D.

Malar J. 2008 Oct 21;7:213. doi: 10.1186/1475-2875-7-213.

Supplemental Content

Support Center